APPLICATION
ANDA206011
TYPE
ANDA
ORIGINAL APPROVAL
2015-04-08
LATEST ACTION
2018-08-15
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ATRACURIUM BESYLATEDiscontinued
ATRACURIUM BESYLATE 10MG/ML · INJECTABLE · INJECTION
Approval history
2018-08-15Labeling · Supplement 2 · standardAP
2015-04-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.